Navigation Links
Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association
Date:11/10/2008

ista Therapeutics

Synvista Therapeutics is a biopharmaceutical company developing diagnostics and drugs to diagnose, treat and prevent cardiovascular disease in people with diabetes. The Company has developed a clinical diagnostic test for Hp2-2 diabetes. The genetic or protein form of this test can be used to identify diabetic patients at high risk for cardiovascular complications. These patients may benefit from a particular formulation of vitamin E. The Company is also developing a kit to measure CML (carboxy-methyllysine), another potential cardiovascular risk marker.

Synvista Therapeutics is developing oral antioxidant drugs to treat the HDL dysfunction seen in Hp2-2 diabetes, a disease affecting almost 7 million patients in the United States. The Company is also developing alagebrium, a proposed breaker of advanced glycation endproducts (AGEs) for the treatment of systolic and diastolic heart failure.

For more information, please visit the Company's Web site at http://www.synvista.com.

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, the risks associated with the events described in this press release, future clinical development of Synvista Therapeutics' diagnostic tests and product candidates, and other risks identified in Synvista Therapeutics' filings with the Securities and Exchange Commission. Further information on risks faced by Synvista are detailed under the caption "Risk Factors" in Synvista Therapeutics' Annual Report on Form 10-K for the year ended December 31, 2007. These filings are available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual resu
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Synvista Therapeutics Posts Letter to Stockholders on Web Site
2. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
3. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
4. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
6. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
7. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
8. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
9. Synvista Therapeutics to be Featured on Wallst.net
10. Synvista Therapeutics to Present at the BIO InvestorForum 2007
11. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... December 17 Biovista Inc.,today announced the ... access,to Biovista,s BEA literature mining platform. BEA will ... that Novus Biologicals is offering to visitors of ... allow site visitors to identify,genes that are related ... and from these browse Novus reagents that have ...
(Date:12/17/2009)... of nimotuzumab - , MISSISSAUGA, ON, Dec. 17 ... YM BioSciences Inc. and Thomas Wellner, President and ... signing of an agreement under which Therapure Biopharma ... the humanized monoclonal antibody licensed to YM,s majority-owned ... of Molecular Immunology (CIM). Under the terms of ...
(Date:12/17/2009)... in 2010, puts healthcare cost control at the head of the ... , ... New York, NY (Vocus) December 17, 2009 -- ... in 2010, puts healthcare cost control at the ... ahead. , , , , ,“Healthcare typically lags trends in the ...
(Date:12/17/2009)... allows users to easily find and schedule an appointment for ... health screening, share comments, view personal stories, and connect with ... health screening company’s new site will improve its usability, ... ... OH (PRWEB) December 17, 2009 -- Visitors to Life Line ...
Breaking Biology Technology:Novus Biologicals Awards Contract to Biovista Inc. to Drive its Web-Based Novus Explorer Service 2YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract 2YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract 3YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract 4Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 2Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 3Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 4Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 5Website Redesign Enhances Global Health Screening Service's Online Presence 2Website Redesign Enhances Global Health Screening Service's Online Presence 3
... to unite Bay Area life science employers and ... an independent,non-profit trade association serving the life science ... for life science careers,announced today the launch of ... science industry., The online employment network is ...
... Teleconference to be Held at 8 a.m. EDT -, ... Drugstore Ltd. (NYSE: NPD ) ("China Nepstar" or ... the number of directly operated,stores, announced today the second ... opens on Wednesday, August 27, 2008., The Company ...
... Non-Fusion Spine Surgeon Supports Company,s Goals for Global ... Medical ... a spine care,services organization that partners with hospitals and physicians ... appointed Dr. Rudolf Bertagnoli, chairman and founder,of ProSpine (Bogen, Germany), ...
Other Biology Technology:BayBio and BioSpace Launch Online Career Network 2China Nepstar Chain Drugstore to Announce Second Quarter 2008 Financial Results on August 27 2SpineMark Appoints Dr. Rudolf Bertagnoli Chairman of International Medical Advisory Board 2
(Date:12/16/2009)... REDWOOD CITY, Calif., Dec. 2 ... and authentication solutions, today announced an agreement ... of its DigitalPersona biometric fingerprint technology on ... U.are.U® 4500HD offering allows point-of-sale applications to ... that specific transactions can be linked to ...
(Date:12/16/2009)... Dec. 7 IgeaCare Solutions Inc. is ... of the healthcare communications company previously operating as ... will now move forward under new leadership and ... Michael Rochon to the position of Chief Executive ... focus on providing a superior servicing and support ...
(Date:12/16/2009)... Va., Dec. 9 CSC (NYSE: ... the American Association for Laboratory Accreditation awarded ... (ISO/IEC) 17025:2005 accreditation to the company,s Test ... Identity Labs located in Fairmont, W.Va. The ... laboratory in the world to achieve this ...
Breaking Biology News(10 mins):DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Jim Kerwin Announces Oxford Communications To Be the Title Sponsor of Bermuda Health Foundation Salute for the Second Year 47705 1Jim Kerwin Announces Oxford Communications To Be the Title Sponsor of Bermuda Health Foundation Salute for the Second Year 47705 2Proplant Awarded Qatar Project 12428 1FDA to Study Ways to Be More Open With Public 47702 1FDA to Study Ways to Be More Open With Public 47702 2FDA to Study Ways to Be More Open With Public 47702 3
... tiny fossil found more than 10 years ago in central ... long unsolved evolutionary question, say researchers from the University of ... research team found a 60 million year-old incomplete skull fossil ... extinct mammal with a venom delivery apparatus. The research will ...
... customized nanoparticles that they developed, University at Buffalo scientists ... brains of living mice with an efficiency that is ... no observable toxic effect, according to a paper published ... Sciences. , The paper describes how the UB scientists ...
... of both humans and chimpanzees has found that much of ... events called segmental duplications, in which segments of genetic code ... as a companion article to the draft sequence of the ... journal Nature. , Dr. Evan Eichler, associate professor of genome ...
Other Biology News:Researchers find first evidence of venom system in extinct mammal 2Using nanoparticles, in vivo gene therapy activates brain stem cells 2Using nanoparticles, in vivo gene therapy activates brain stem cells 3Big differences in duplicated DNA distinguish chimp and human genomes 2
Request Info...
Request Info...
... ,ICC and IHC Protocol Development ,Antibody ... Screenings in Animal or Human Cells ... Cells and Tissues ,Peroxidase, Alkaline Phosphatase, ... or Electron Microscopy ,Protein Localization in ...
Use our experts and resources to develop reagent systems for your applications....
Biology Products: